USD 911.0 million
Microbiome Market Size, Share, and Growth Analysis
Microbiome Market By Product (Probiotics, Foods), By Application (Therapeutics, Diagnostics), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35J2043 |
Region:
Global |
Published Date: January, 2025
Pages:
224
|Tables:
92
|Figures:
76
Format -
Microbiome Market Insights
Global Microbiome Market size was valued at USD 911.0 million in 2023 and is poised to grow from USD 1072.25 million in 2024 to USD 3949.18 million by 2032, growing at a CAGR of 17.7% during the forecast period (2025-2032).
Microbiome is a collection of microorganisms that live on and within our bodies. The United States National Institutes of Health (NIH) started the Human Microbiome Project to increase understanding of the microbial flora involved in human health and disease. The market is expanding as a result of factors such as an increase in the number of strategic alliances for microbiome therapies for R&D, product development, the anticipated introduction of innovative medications, and portfolio enhancement. For example, Hudson Institute and BiomeBank announced a four-year agreement in January 2022 to develop and discover microbial treatments. Furthermore, the increasing prevalence of target diseases is driving up demand for microbiome therapies.
US Microbiome Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
Largest Segment
robiotics
Fastest Growth
robiotics
Growth Rate
17.7% CAGR
Global Microbiome Market By product($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Microbiome Market Segments Analysis
Global Microbiome Market is segmented by Product, Application and region. Based on Product, the market is segmented into Probiotics, Foods, Prebiotics, Medical food and Others. Based on Application, the market is segmented into Therapeutics and Diagnostics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Microbiome Market Analysis by Application
Based on the application, the market is segmented into therapeutics, diagnostics, nutrition and dietics, others. Among these, the digital therapeutics segment of the market is projected to hold the most substantial share in the market. The increase in funding for R&D into microbiome-based medicines around the world is a major element driving the expansion of this application area. Furthermore, technological developments, an increase in the number of clinical trials for the diagnostics segment, and increased collaborations between leading market players and research institutes are all boosting market expansion.
Global Microbiome Market By product
To get detailed analysis on other segments, Request For Free Sample Report
Microbiome Market Regional Insights
North America is expected to account for the lion's share of the global human microbiome market. The region's domination is due to the rising prevalence of lifestyle problems and advances in next-generation sequencing. For example, Illumina Inc., a major player in the United States, claims that the introduction of next-generation sequencing enables various high-profile joint projects, like the Human Microbiome Project and MetaHIT. Using Next Generation Sequencing as a basic tool, these projects have published a wide range of data on the human microbiome.
Europe is likely to increase its market share during the forecast period as a result of extensive research and development of novel human microbiome applications. According to NCBI, new microbiome programmes such as ONCOBIOME, MICROB-predict, and GEMMA are focused on oncology, mapping of human microbiota, and autistic spectrum disorders, respectively, and are expected to boost market expansion in this region in March 2020.
Global Microbiome Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Microbiome Market Dynamics
Microbiome Market Driver
Increasing focus on human microbiome therapeutics development
- Human gut microbiomes play a significant impact in the efficacy of medicinal drugs. Several studies have demonstrated that the appropriate balance of microorganisms in the human body can help treat a variety of illnesses. This link between bacteria and specific disease states could open up new avenues for medication development (or vaccine manufacturers). Because microbes are rich in enzymes, they can be exploited in a variety of therapeutic applications, such as the search for novel medicines.
- Microbiome treatment has grown in popularity. Over a ten-year period, the National Institutes of Health (NIH) spent USD 215 million on the Human Microbiome Project (HMP) and USD 728 million on extramural human microbiome research initiatives outside of the HMP. Similarly, the European Commission established the Metagenomics of the Human Intestinal Tract (MetaHIT) initiative, which is primarily concerned with gut microbes. This project received USD 15 million investments from 2008 - 2012. MetaCardis (Metagenomics in Cardiometabolic Disorders), a large EU-funded research project that explored the function of gut bacteria in cardiometabolic diseases, received a USD 14 million (EUR 12 million) investment from 2012 to 2018. (CMDs). Similarly, Horizon 2020 is one of the largest EU R&I projects, with about USD 96.9 million (€80 billion) available over seven years (2014 to 2020).
Microbiome Market Restraint
Government Regulations Restricting the Market Growth
- Probiotics have not been approved by the FDA as a live biotherapeutic product (a biological product other than a vaccine that contains live organisms used to prevent or treat a disease or condition in humans). Nonetheless, FDA-regulated foods containing probiotics, including dietary supplements, are legally available; however, these items cannot be legitimately advertised to cure, mitigate, treat, or prevent any diseases.
- Probiotic supplements are heavily promoted in retail stores and on the Internet. Although no probiotic has been licenced by the FDA for therapeutic reasons as of yet, some are now undergoing clinical trials and may be sold as biologics or other medications in the near future. The existing FDA regulatory regulations do not apply to probiotics. Given the future market potential for probiotics, it is possible that the FDA will issue regulations requiring research/clinical studies. It has been suggested that probiotics with drug claims be subjected to the same standards as other medications under the Abbreviated New Drug Application (ANDA) procedure. This will also allow probiotics to be exempted from Phase I studies, the first step in the research process. This may hamper the growth of the human microbiome market since big investors will have to invest more in R&D.
Request Free Customization of this report to help us to meet your business objectives.
Microbiome Market Competitive Landscape
The market is fragmented in nature. The prominent players operating in the market are constantly adopting various growth strategies in order to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D in order to supply industries with the most efficient and cost-effective solutions.
Top Players in Microbiome Market
- Seres Therapeutics (USA)
- Ferring Pharmaceuticals (Switzerland)
- BiomeBank (Australia)
- Seed Health (USA)
- International Flavors & Fragrances Inc. (USA)
- Pendulum Therapeutics (USA)
- BioHM Health Inc. (USA)
- Actial Farmaceutica SRL (Italy)
- Optibiotix Health plc (UK)
- Resbiotic (USA)
- Infinant Health Inc. (USA)
- Biogaia AB (Sweden)
- Exegi Pharma LLC (USA)
- Vedanta Biosciences Inc. (USA)
- Enterome (France)
- Yakult (Japan)
- DuPont (USA)
- Metabiomics Corporation (USA)
- ViThera Pharmaceuticals (USA)
- Second Genome (USA)
Microbiome Market Recent Developments
- In September 2022, Seres Therapeutics Inc completed the FDA BLA submission procedure for SER-109 to prevent recurrent C. difficile infection (rCDI). It is a completely novel therapy approach that has the potential to improve the existing standard of care for rCDI.
- In September 2022, The FDA's Vaccines and Related Biological Products Advisory Committee approved Ferring Pharmaceuticals' RBX2660 investigational microbiota-based live biotherapeutic research for its potential to decrease the recurrence of C. difficile infection (CDI) after antibiotic therapy.
Microbiome Key Market Trends
- Increasing collaborations between public-private organizations: With several small innovative players in the market, there are several high-growth opportunities for key stakeholders to buy out companies in order to study microbiomes in the hope of identifying new drugs and drug targets for various indications such as obesity, liver disorders, diabetes, and metabolic disorders. Many market leaders are working on strategic collaborations and partnerships to expand their product pipelines through well-organized R&D approaches. Many alliances and partnerships involving large corporations have occurred in the recent two years.
Microbiome Market SkyQuest Analysis
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to our analysis, Global Microbiome market is segmented based on product, application, distribution channel and region. Based on the product, the probiotics segment is projected to hold a significant share in the market. Based on the application, the therapeutics segment is projected to hold a significant share in the market. Based on the distribution channel, the retail pharmacies segment is projected to hold a significant share in the market. Based on the region, North America region holds a substantial market share.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 911.0 million |
| Market size value in 2032 | USD 3949.18 million |
| Growth Rate | 17.7% |
| Base year | 2024 |
| Forecast period | 2025-2032 |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Microbiome Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Microbiome Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Microbiome Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Microbiome Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Microbiome Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Microbiome Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
